Quince Therapeutics, Inc. · NASDAQ:QNCX
Integrated Core Strategies (US) LLC reported a 7.20% stake in Quince Therapeutics, Inc. (Schedule 13G)
Event Jun 4, 2026 · Filed Jun 10, 2026
Integrated Core Strategies (US) LLC reported a 7.20% stake in Quince Therapeutics, Inc., 1,403,580 shares, as a passive investor on Jun 4, 2026. Filed Jun 10, 2026 (Schedule 13G).
- Stake
- 7.20%
- Shares
- 1,403,580
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Integrated Core Strategies (US) LLC | 7.20% | 1,403,580 |
| Millennium Management LLC | 7.20% | 1,403,697 |
| Millennium Group Management LLC | 7.20% | 1,403,697 |
| Israel A. Englander | 7.20% | 1,403,697 |